Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
2,087 Dermatology
clinical trials

Atopic Dermatitis Clinical Trial
Drug-drug Interaction Trial With Tralokinumab in Moderate to Severe Atopic Dermatitis - ECZTRA 4
Status: Enrolling, Phase I
Updated: 12/31/1969
LEO Pharma Investigational Site
mi
from
Little Rock, AR
Click here to add this to my saved trials
Acne Vulgaris Clinical Trial
Bioequivalence Study of Clindamycin Phosphate Topical Lotion, 1% in Subjects With Acne Vulgaris
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Chattanooga, TN
Click here to add this to my saved trials
Acne Vulgaris Clinical Trial
Bioequivalence Study of Clindamycin Phosphate Topical Lotion, 1% in Subjects With Acne Vulgaris
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Largo, FL
Click here to add this to my saved trials
Acne Vulgaris Clinical Trial
Bioequivalence Study of Clindamycin Phosphate Topical Lotion, 1% in Subjects With Acne Vulgaris
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Murfreesboro, TN
Click here to add this to my saved trials
Acne Vulgaris Clinical Trial
Bioequivalence Study of Clindamycin Phosphate Topical Lotion, 1% in Subjects With Acne Vulgaris
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Rogers, AR
Click here to add this to my saved trials
Acne Vulgaris Clinical Trial
Bioequivalence Study of Clindamycin Phosphate Topical Lotion, 1% in Subjects With Acne Vulgaris
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Saint Petersburg, FL
Click here to add this to my saved trials
Acne Vulgaris Clinical Trial
Bioequivalence Study of Clindamycin Phosphate Topical Lotion, 1% in Subjects With Acne Vulgaris
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
San Diego, CA
Click here to add this to my saved trials
Acne Vulgaris Clinical Trial
Bioequivalence Study of Clindamycin Phosphate Topical Lotion, 1% in Subjects With Acne Vulgaris
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Warwick, RI
Click here to add this to my saved trials
Common Wart Clinical Trial
Study of A-101 Topical Solution for the Treatment of Common Warts
Status: Enrolling, Phase III
Updated: 12/31/1969
Aclaris Investigational Site
mi
from
Aventura, FL
Click here to add this to my saved trials
Common Wart Clinical Trial
Study of A-101 Topical Solution for the Treatment of Common Warts
Status: Enrolling, Phase III
Updated: 12/31/1969
Aclaris Investigational Site
mi
from
Charleston, SC
Click here to add this to my saved trials
Common Wart Clinical Trial
Study of A-101 Topical Solution for the Treatment of Common Warts
Status: Enrolling, Phase III
Updated: 12/31/1969
Aclaris Investigational Site
mi
from
Fridley, MN
Click here to add this to my saved trials
Common Wart Clinical Trial
Study of A-101 Topical Solution for the Treatment of Common Warts
Status: Enrolling, Phase III
Updated: 12/31/1969
Aclaris Investigational Site
mi
from
Newnan, GA
Click here to add this to my saved trials
Common Wart Clinical Trial
Study of A-101 Topical Solution for the Treatment of Common Warts
Status: Enrolling, Phase III
Updated: 12/31/1969
Aclaris Investigational Site
mi
from
San Diego, CA
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Oncology Clinical Trial
A Study of IMMray™ PanCan-d Test for Early Detection of Pancreatic Cancer in High-risk Groups
Status: Enrolling, Phase
Updated: 12/31/1969
Mount Sinai Hosp
mi
from
New York, NY
Click here to add this to my saved trials
Urticaria Clinical Trial
A Study to Evaluate the Long-term Safety and Efficacy of Fenebrutinib in Participants Previously Enrolled in a Fenebrutinib Chronic Spontaneous Urticaria (CSU) Study
Status: Enrolling, Phase II
Updated: 12/31/1969
Integrated Research of Inland
mi
from
Upland, CA
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
A Study to Assess the Efficacy and Safety of MSTT1041A in Participants With Moderate to Severe Atopic Dermatitis
Status: Enrolling, Phase II
Updated: 12/31/1969
Charite -Universitätsmedizin Berlin
mi
from
Berlin,
Click here to add this to my saved trials
Chronic Hand Dermatitis Clinical Trial
Study to Evaluate ASN002 in Subjects With Severe Chronic Hand Eczema
Status: Enrolling, Phase II
Updated: 12/31/1969
Dermatologists of Greater Colombus
mi
from
Bexley, OH
Click here to add this to my saved trials
Chronic Hand Dermatitis Clinical Trial
Study to Evaluate ASN002 in Subjects With Severe Chronic Hand Eczema
Status: Enrolling, Phase II
Updated: 12/31/1969
ActivMed Practices & Research, Inc.
mi
from
Portsmouth, NH
Click here to add this to my saved trials
Alopecia Areata Clinical Trial
PF-06651600 for the Treatment of Alopecia Areata
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Advanced Clinical Research at Treasure Valley Dermatology and Skin Cancer Center
mi
from
Boise, ID
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Efficacy, Safety, and Pharmacokinetic Profiles of REGN3500 Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis
Status: Enrolling, Phase II
Updated: 12/31/1969
Regeneron Research Site
mi
from
Norman, OK
Click here to add this to my saved trials
Acne Vulgaris Clinical Trial
Sebacia Postmarket Study of Real-World Use
Status: Enrolling
Updated: 12/31/1969
International Clinical Research
mi
from
Murfreesboro, TN
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
JAK1 Inhibitor With Medicated Topical Therapy in Adolescents With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Advanced Clinical Research at Treasure Valley Dermatology and Skin Cancer Center
mi
from
Boise, ID
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
JAK1 Inhibitor With Medicated Topical Therapy in Adolescents With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Forefront Dermatology, S.C.
mi
from
Louisville, KY
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Dose-ranging Trial to Evaluate Delgocitinib Cream 1, 3, 8, and 20 mg/g Compared to Delgocitinib Cream Vehicle Over an 8-week Treatment Period in Adult Subjects With Atopic Dermatitis.
Status: Enrolling, Phase II
Updated: 12/31/1969
Leo Pharma Investigational Site
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Acne Vulgaris Clinical Trial
Evaluation of BTX 1503 in Patients With Moderate to Severe Acne Vulgaris
Status: Enrolling, Phase II
Updated: 12/31/1969
DelRicht Research
mi
from
New Orleans, LA
Click here to add this to my saved trials
Alopecia Areata Clinical Trial
Efficacy and Tolerability Study of Two Dose Regimens of CTP-543 in Adults Patients With Alopecia Areata
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Fridley, MN
Click here to add this to my saved trials
Alopecia Areata Clinical Trial
Efficacy and Tolerability Study of Two Dose Regimens of CTP-543 in Adults Patients With Alopecia Areata
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
mi
from
New Haven, CT
Click here to add this to my saved trials
Alopecia Areata Clinical Trial
Efficacy and Tolerability Study of Two Dose Regimens of CTP-543 in Adults Patients With Alopecia Areata
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Portland, OR
Click here to add this to my saved trials
Alopecia Areata Clinical Trial
Efficacy and Tolerability Study of Two Dose Regimens of CTP-543 in Adults Patients With Alopecia Areata
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
mi
from
San Francisco, CA
Click here to add this to my saved trials
Common Wart Clinical Trial
Safety Study of A-101 Topical Solution for the Treatment of Common Warts
Status: Enrolling, Phase III
Updated: 12/31/1969
Aclaris Investigational Site
mi
from
Austin, TX
Click here to add this to my saved trials
Common Wart Clinical Trial
Safety Study of A-101 Topical Solution for the Treatment of Common Warts
Status: Enrolling, Phase III
Updated: 12/31/1969
Aclaris Investigational Site
mi
from
Fountain Valley, CA
Click here to add this to my saved trials
Common Wart Clinical Trial
Safety Study of A-101 Topical Solution for the Treatment of Common Warts
Status: Enrolling, Phase III
Updated: 12/31/1969
Aclaris Investigational Site
mi
from
Knoxville, TN
Click here to add this to my saved trials
Common Wart Clinical Trial
Safety Study of A-101 Topical Solution for the Treatment of Common Warts
Status: Enrolling, Phase III
Updated: 12/31/1969
Aclaris Investigational Site
mi
from
Raleigh, NC
Click here to add this to my saved trials
Common Wart Clinical Trial
Safety Study of A-101 Topical Solution for the Treatment of Common Warts
Status: Enrolling, Phase III
Updated: 12/31/1969
Aclaris Investigational Site
mi
from
Rockville, MD
Click here to add this to my saved trials
Common Wart Clinical Trial
Safety Study of A-101 Topical Solution for the Treatment of Common Warts
Status: Enrolling, Phase III
Updated: 12/31/1969
Aclaris Investigational Site
mi
from
Verona, NJ
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
A Study of LY3375880 in Adults With Moderate-to-Severe Atopic Dermatitis
Status: Enrolling, Phase II
Updated: 12/31/1969
ActivMed Practices & Research, Inc.
mi
from
Portsmouth, NH
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
A Study of LY3375880 in Adults With Moderate-to-Severe Atopic Dermatitis
Status: Enrolling, Phase II
Updated: 12/31/1969
Arlington Dermatology
mi
from
Rolling Meadows, IL
Click here to add this to my saved trials
Atopic Dermatitis Eczema Clinical Trial
Study in Subjects With Moderate Atopic Dermatitis
Status: Enrolling, Phase II
Updated: 12/31/1969
Ralexar Investigational Site 23
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
A Dose Ranging Placebo-Controlled Double-Blind Study to Evaluate the Safety and Efficacy of Tezepelumab in Atopic Dermatitis
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Spokane, WA
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
A Dose Ranging Placebo-Controlled Double-Blind Study to Evaluate the Safety and Efficacy of Tezepelumab in Atopic Dermatitis
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Stony Brook, NY
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
A Dose Ranging Placebo-Controlled Double-Blind Study to Evaluate the Safety and Efficacy of Tezepelumab in Atopic Dermatitis
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Sydney,
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
A Study to Assess the Safety and Efficacy of ZPL389 in Patients With Moderate to Severe Atopic Dermatitis
Status: Enrolling, Phase II
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Fairborn, OH
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
A Study to Assess the Safety and Efficacy of ZPL389 in Patients With Moderate to Severe Atopic Dermatitis
Status: Enrolling, Phase II
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Pflugerville, TX
Click here to add this to my saved trials
Hidradenitis Suppurativa Clinical Trial
This is a Study of Efficacy and Safety of Two Secukinumab Dose Regimens in Subjects With Moderate to Severe Hidradenitis Suppurativa (HS).
Status: Enrolling, Phase III
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Rogers, AR
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Hematology, Immunology / Infectious Diseases, Oncology, Reproductive Clinical Trial
CA-IX, p16, Proliferative Markers, and HPV in Diagnosing Cervical Lesions in Patients With Abnormal Cervical Cells
Status: Enrolling, Phase
Updated: 12/31/1969
Saint Alphonsus Cancer Care Center-Caldwell
mi
from
Caldwell, ID
Click here to add this to my saved trials
Human Papillomavirus Infection Clinical Trial
A Phase III Study of a 2-dose Regimen of a Multivalent Human Papillomavirus (HPV) Vaccine (V503), Administered to 9 to 14 Year-olds and Compared to Young Women, 16 to 26 Years Old (V503-010)
Status: Enrolling, Phase III
Updated: 4/18/2014
Clinical Research Facility
mi
from
Galveston, TX
Click here to add this to my saved trials
Human Papillomavirus Infection Clinical Trial
A Phase III Study of a 2-dose Regimen of a Multivalent Human Papillomavirus (HPV) Vaccine (V503), Administered to 9 to 14 Year-olds and Compared to Young Women, 16 to 26 Years Old (V503-010)
Status: Enrolling, Phase III
Updated: 4/18/2014
Clinical Research Facility
mi
from
Woburn, MA
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Immunology / Infectious Diseases, Oncology, Reproductive Clinical Trial
Topical or Ablative Treatment in Preventing Anal Cancer in Patients With HIV and Anal High-Grade Squamous Intraepithelial Lesions
Status: Enrolling, Phase III
Updated: 12/31/1969
Capital Digestive Care
mi
from
Washington DC,
Click here to add this to my saved trials
Acne Vulgaris Clinical Trial
A Study to Evaluate the Safety and Efficacy of Omiganan (CLS001) Topical Gel Versus Vehicle in Female Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling, Phase II
Updated: 2/29/2016
Clinical Research Facility
mi
from
Arlington, TX
Click here to add this to my saved trials
Acne Vulgaris Clinical Trial
A Study to Evaluate the Safety and Efficacy of Omiganan (CLS001) Topical Gel Versus Vehicle in Female Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling, Phase II
Updated: 2/29/2016
Clinical Research Facility
mi
from
Boynton Beach, FL
Click here to add this to my saved trials
Acne Vulgaris Clinical Trial
A Study to Evaluate the Safety and Efficacy of Omiganan (CLS001) Topical Gel Versus Vehicle in Female Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling, Phase II
Updated: 2/29/2016
Clinical Research Facility
mi
from
Denver, CO
Click here to add this to my saved trials
Acne Vulgaris Clinical Trial
A Study to Evaluate the Safety and Efficacy of Omiganan (CLS001) Topical Gel Versus Vehicle in Female Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling, Phase II
Updated: 2/29/2016
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
Acne Vulgaris Clinical Trial
A Study to Evaluate the Safety and Efficacy of Omiganan (CLS001) Topical Gel Versus Vehicle in Female Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling, Phase II
Updated: 2/29/2016
Clinical Research Facility
mi
from
Newington, NH
Click here to add this to my saved trials
Acne Vulgaris Clinical Trial
A Study to Evaluate the Safety and Efficacy of Omiganan (CLS001) Topical Gel Versus Vehicle in Female Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling, Phase II
Updated: 2/29/2016
Clinical Research Facility
mi
from
Santa Monica, CA
Click here to add this to my saved trials
Acne Vulgaris Clinical Trial
A Study to Determine the Efficacy of Topically Applied MTC896 Gel in Subjects With Acne Vulgaris
Status: Enrolling, Phase II
Updated: 1/21/2016
Clinical Research Facility
mi
from
College Station, TX
Click here to add this to my saved trials
Acne Vulgaris Clinical Trial
A Study to Determine the Efficacy of Topically Applied MTC896 Gel in Subjects With Acne Vulgaris
Status: Enrolling, Phase II
Updated: 1/21/2016
Clinical Research Facility
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Acne Vulgaris Clinical Trial
A Study to Determine the Efficacy of Topically Applied MTC896 Gel in Subjects With Acne Vulgaris
Status: Enrolling, Phase II
Updated: 1/21/2016
Clinical Research Facility
mi
from
Plano, TX
Click here to add this to my saved trials
Acne Vulgaris Clinical Trial
A Study to Determine the Efficacy of Topically Applied MTC896 Gel in Subjects With Acne Vulgaris
Status: Enrolling, Phase II
Updated: 1/21/2016
Clinical Research Facility
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Acne Vulgaris Clinical Trial
A Study to Determine the Efficacy of Topically Applied MTC896 Gel in Subjects With Acne Vulgaris
Status: Enrolling, Phase II
Updated: 1/21/2016
Clinical Research Facility
mi
from
Sanford, FL
Click here to add this to my saved trials
Acne Vulgaris Clinical Trial
A Study to Determine the Efficacy of Topically Applied MTC896 Gel in Subjects With Acne Vulgaris
Status: Enrolling, Phase II
Updated: 1/21/2016
Clinical Research Facility
mi
from
Spokane, WA
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
To Study Generic Tacrolimus Ointment, 0.1% in the Treatment of Moderate to Severe Atopic Dermatitis (Inflammation of Skin: Itchy, Red, Swollen, and Cracked Skin)
Status: Enrolling, Phase III
Updated: 7/6/2016
Glenmark Investigational Site 60
mi
from
Baytown, TX
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
To Study Generic Tacrolimus Ointment, 0.1% in the Treatment of Moderate to Severe Atopic Dermatitis (Inflammation of Skin: Itchy, Red, Swollen, and Cracked Skin)
Status: Enrolling, Phase III
Updated: 7/6/2016
Glenmark Investigational Site 59
mi
from
Hialeah Gardens, FL
Click here to add this to my saved trials
Dermatitis, Eczematous Clinical Trial
Clinical Evaluation of Metal Panel Allergens: Dose Response Study
Status: Enrolling, Phase II
Updated: 4/6/2018
Ludwig-Maximilians-Universitat Munchen
mi
from
Munich,
Click here to add this to my saved trials
Dermatochalasis Clinical Trial
Topical Bimatoprost for Chemical Blepharoplasty
Status: Enrolling, Phase
Updated: 12/7/2016
Tulane Department of Dermatology
mi
from
New Orleans, LA
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Austin, TX
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Bakersfield, CA
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Buffalo, NY
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Centennial, CO
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Chattanooga, TN
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Clearwater, FL
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
East Windsor, NJ
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Encinitas, CA
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Fridley, MN
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Richmond, VA
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Saint Joseph, MO
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
San Diego, CA
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Savannah, GA
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Seattle, WA
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Waco, TX
Click here to add this to my saved trials
Atopic Dermatitis (AD) Clinical Trial
Targeted Microbiome Transplant in Atopic Dermatitis
Status: Enrolling, Phase I, II
Updated: 12/31/1969
National Jewish Health General Clinical Research Center
mi
from
Denver, CO
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Evaluating the Effects of Cleansers on the Skin
Status: Enrolling
Updated: 12/31/1969
University of Arizona, Banner-University Medical Center
mi
from
Tucson, AZ
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Neurology Clinical Trial
Brentuximab Vedotin for Systemic Sclerosis
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Hospital for Special Surgery, New York: Division of Rheumatology
mi
from
New York, NY
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Neurology Clinical Trial
Brentuximab Vedotin for Systemic Sclerosis
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Georgetown University Medical Center: Division of Rheumatology
mi
from
Washington DC,
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Ophthalmology Clinical Trial
Epi-On Corneal Crosslinking for Keratoconus
Status: Enrolling, Phase IV
Updated: 12/31/1969
Comprehensive EyeCare of Central Ohio
mi
from
Westerville, OH
Click here to add this to my saved trials
Dermatitis, Atopic Clinical Trial
Safety, Pharmacokinetics and Efficacy of Dupilumab in Patients ≥6 Months to
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Regeneron Investigational Site
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Dermatitis, Atopic Clinical Trial
Safety, Pharmacokinetics and Efficacy of Dupilumab in Patients ≥6 Months to
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Regeneron Investigational Site
mi
from
Macon, GA
Click here to add this to my saved trials
Dermatitis, Atopic Clinical Trial
Safety, Pharmacokinetics and Efficacy of Dupilumab in Patients ≥6 Months to
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Regeneron Investigational Site
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
A Study of Crisaborole Ointment 2% in Children Aged 3-24 Months With Mild to Moderate Atopic Dermatitis
Status: Enrolling, Phase IV
Updated: 12/31/1969
Pediatric Associates of Charlottesville, PLC
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
A Study of Crisaborole Ointment 2% in Children Aged 3-24 Months With Mild to Moderate Atopic Dermatitis
Status: Enrolling, Phase IV
Updated: 12/31/1969
Timber Lane Allergy & Asthma Research, LLC
mi
from
South Burlington, VT
Click here to add this to my saved trials
Dermatitis, Atopic Clinical Trial
Study to Evaluate Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years And Older With Moderate to Severe Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Medical University of South Carolina Investigational Drug Service
mi
from
Charleston, SC
Click here to add this to my saved trials
Dermatitis, Atopic Clinical Trial
Study to Evaluate Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years And Older With Moderate to Severe Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
MediSearch Clinical Trials
mi
from
Saint Joseph, MO
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Efficacy and Safety of PR022 Topical Gel to Treat Mild-to-Moderate Atopic Dermatitis
Status: Enrolling, Phase II
Updated: 12/19/2017
Principal Investigator
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Diffuse Cutaneous Systemic Sclerosis Clinical Trial
Trial to Evaluate Efficacy and Safety of Lenabasum in Diffuse Cutaneous Systemic Sclerosis
Status: Enrolling, Phase III
Updated: 12/31/1969
Michigan Medicine
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Diffuse Cutaneous Systemic Sclerosis Clinical Trial
Trial to Evaluate Efficacy and Safety of Lenabasum in Diffuse Cutaneous Systemic Sclerosis
Status: Enrolling, Phase III
Updated: 12/31/1969
John Hopkins University, Scleroderma Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
Ichthyosis Vulgaris Clinical Trial
A Six Week Topical Cream Study for Subjects With Ichthyosis Vulgaris
Status: Enrolling, Phase II
Updated: 12/31/1969
Crown Investigative site 04
mi
from
Columbia, MO
Click here to add this to my saved trials
Urticaria Clinical Trial
Efficacy and Safety of GDC-0853 in Participants With Refractory Chronic Spontaneous Urticaria (CSU)
Status: Enrolling, Phase II
Updated: 12/31/1969
Integrated Research of Inland
mi
from
Upland, CA
Click here to add this to my saved trials
1 … 8 9 10 11 12 13 14 15 16 17 18 19 20 21